Cargando…

Effects of the Mediterranean Diet on Cardiovascular Outcomes—A Systematic Review and Meta-Analysis

BACKGROUND: A Mediterranean dietary pattern is widely recommended for the prevention of chronic disease. We sought to define the most likely effects of the Mediterranean diet on vascular disease and mortality. METHODS: We searched MEDLINE, EMBASE and the Cochrane Central Register without language re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liyanage, Thaminda, Ninomiya, Toshiharu, Wang, Amanda, Neal, Bruce, Jun, Min, Wong, Muh Geot, Jardine, Meg, Hillis, Graham S., Perkovic, Vlado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980102/ https://www.ncbi.nlm.nih.gov/pubmed/27509006 http://dx.doi.org/10.1371/journal.pone.0159252

Ejemplares similares

Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis
por: Sukkar, Louisa, et al.
Publicado: (2016)

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis
por: Lv, Jicheng, et al.
Publicado: (2012)

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
por: Heerspink, Hiddo J Lambers, et al.
Publicado: (2009)

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis
por: Jardine, Meg J, et al.
Publicado: (2012)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
por: Perkovic, Vlado, et al.
Publicado: (2008)

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
por: Neuen, Brendon L, et al.
Publicado: (2020)

Prevalence of chronic kidney disease in Asia: a systematic review and analysis
por: Liyanage, Thaminda, et al.
Publicado: (2022)

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes
por: Neuen, Brendon L., et al.
Publicado: (2020)

Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program
por: Wang, Katherine M., et al.
Publicado: (2021)

Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Arnott, Clare, et al.
Publicado: (2020)

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis
por: Ren, Song, et al.
Publicado: (2017)

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program
por: Neuen, Brendon L., et al.
Publicado: (2018)

Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
por: Jun, Min, et al.
Publicado: (2019)

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
por: Zhou, Zien, et al.
Publicado: (2021)

A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation
por: Feng, Yunlin, et al.
Publicado: (2022)

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review
por: Smyth, Brendan, et al.
Publicado: (2019)

Biomarkers in kidney fibrosis: are they useful?
por: Wong, Muh Geot, et al.
Publicado: (2014)

Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA(1c), disease duration and treatment intensity: results from the CANVAS Program
por: Young, Tamara K., et al.
Publicado: (2021)

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program
por: Zhou, Zien, et al.
Publicado: (2019)

Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
por: Yu, Jie, et al.
Publicado: (2021)

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials
por: Fletcher, Robert A., et al.
Publicado: (2023)

Cardiovascular prevention: Mediterranean or low-fat diet?
por: Temporelli, Pier Luigi
Publicado: (2023)

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
por: Mahaffey, Kenneth W., et al.
Publicado: (2018)

Lessons for the clinical nephrologist: ureteric obstruction secondary to blood clot after kidney biopsy
por: O’Hara, Daniel V., et al.
Publicado: (2021)

The renal consequences of maternal obesity in offspring are overwhelmed by postnatal high fat diet
por: Glastras, Sarah J., et al.
Publicado: (2017)

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From the Randomized CREDENCE Trial
por: Mahaffey, Kenneth W., et al.
Publicado: (2019)

IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study
por: Barratt, Jonathan, et al.
Publicado: (2023)

Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial
por: Li, Jing‐Wei, et al.
Publicado: (2022)

Mediterranean Diet and Mortality in People with Cardiovascular Disease: A Meta-Analysis of Prospective Cohort Studies
por: Tang, Chengyao, et al.
Publicado: (2021)

Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss
por: Pérez-Guisado, Joaquín, et al.
Publicado: (2008)

New hypoglycemic agents and the kidney: what do the major trials tell us?
por: Smyth, Brendan, et al.
Publicado: (2018)

A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-β(1)
por: Zhang, Jie, et al.
Publicado: (2015)

Correction: A Cationic-Independent Mannose 6-Phosphate Receptor Inhibitor (PXS64) Ameliorates Kidney Fibrosis by Inhibiting Activation of Transforming Growth Factor-β1
por: Zhang, Jie, et al.
Publicado: (2022)

Transferability of the Mediterranean Diet to Non-Mediterranean Countries. What Is and What Is Not the Mediterranean Diet
por: Martínez-González, Miguel Ángel, et al.
Publicado: (2017)

The Impact of Abdominal Obesity Status on Cardiovascular Response to the Mediterranean Diet
por: Bédard, Alexandra, et al.
Publicado: (2012)

Nutritional Genomics and the Mediterranean Diet’s Effects on Human Cardiovascular Health
por: Fitó, Montserrat, et al.
Publicado: (2016)

Book Review: The Prevention of Cardiovascular Disease Through the Mediterranean Diet
por: Asamudo, Esther Udo, et al.
Publicado: (2019)

Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

The Mediterranean Diet
por: Preedy, Victor
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p58c1nn08j6mb3oovvkl3bd5a6